StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hansa Biopharma AB (publ)
Stockholm Stock Exchange:HNSA.ST
Sector
Industries
Location
Market Cap
USD 236.80 M
Share Price
USD 2.74
Avg Daily Volume
231,100
Change (1 day)
1.24%
Change (1 year)
-26.01%
Change (YTD)
-22.50%
Hansa Biopharma AB (publ) EBITDA Margin for the year ending December 31, 2024: -374.79%
Hansa Biopharma AB (publ) EBITDA Margin is -374.79% for the year ending December 31, 2024, a -29.67% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Hansa Biopharma AB (publ) EBITDA Margin for the year ending December 31, 2023 was -532.88%, a 48.56% change year over year.
-
Hansa Biopharma AB (publ) EBITDA Margin for the year ending December 31, 2022 was -358.69%, a -77.45% change year over year.
-
Hansa Biopharma AB (publ) EBITDA Margin for the year ending December 31, 2021 was -1,590.50%, a -76.52% change year over year.
-
Hansa Biopharma AB (publ) EBITDA Margin for the year ending December 31, 2020 was -6,774.09%, a -35.30% change year over year.
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Siemens Healthineers AG
USD 54.74
SHL.DE
+1.05
1.95%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Siemens Healthineers AG
USD 54.74
SHL.DE
+1.05
1.95%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%